In hypercholesterolemic ApoE3*Leiden mice, co-stimulation blockade with the CTLA-4 fusion protein abatacept attenuated atherosclerosis development via reducing T-cell activation, decreasing circulating IFNγ and increasing IL-10 levels [34]. Here, CTLA4 is linked to atherosclerosis.